Legal Representation
Attorney
Sarah Anne Keefe
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 8, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Apr 8, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Dec 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Dec 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 4, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Therapeutic pharmaceuticals for use in the treatment of cancer
Additional Information
Design Mark
The mark consists of stylized word "PHIO" stacked above the word "PHARMACEUTICALS" to the right of a stylized letter "P".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005